Sarah Schwartzberg's GLP-1 medication video fact-checked

A TikTok from @itz.sarahrose showing her smiling while mentioning that GLP-1 medications are making her "feel okay" has racked up 94,400 views. While her brief caption doesn't make specific medical claims, it touches on the mood and psychological effects that some people report with these drugs.

What does this video actually claim?

The video makes a subtle claim that GLP-1 medications improved the creator's mood or emotional state. Sarah's caption suggests the medication is responsible for her feeling "okay" enough to smile, implying a positive psychological effect.

This type of anecdotal report isn't uncommon in GLP-1 communities online. Many users describe feeling better emotionally while taking semaglutide, tirzepatide, or liraglutide, though they often can't separate whether it's from the drug itself or from weight loss results.

The video doesn't specify which GLP-1 medication she's taking or make broader claims about efficacy. It's more of a personal mood check-in than a medical testimonial.

Do GLP-1 medications actually affect mood?

There's limited direct evidence that GLP-1 receptor agonists improve mood as a primary effect. Most studies focus on weight loss and diabetes management, not psychological outcomes.

The STEP 1 trial (Wilding et al., NEJM, 2021) found 14.9% weight loss with 2.4mg semaglutide at 68 weeks, but didn't specifically measure mood changes. However, participants did report improved quality of life scores, which could overlap with feeling "okay."

A 2022 study in Diabetes Care (Utzschneider et al.) found that people taking semaglutide had better eating-related quality of life compared to placebo groups. Some researchers theorize that GLP-1 drugs might affect brain reward pathways, potentially influencing mood indirectly.

The more likely explanation? Weight loss itself often improves mood and self-esteem, making it hard to separate drug effects from results.

What's missing from this picture?

Sarah's video doesn't mention any of the common side effects that might make someone feel decidedly not okay. About 44% of people taking 2.4mg semaglutide in clinical trials experienced nausea, and 24% had vomiting.

The SUSTAIN-1 trial (Sorli et al., Diabetes Care, 2017) found that 5% of participants stopped taking 1mg semaglutide due to gastrointestinal side effects. Those people probably weren't smiling about how the medication made them feel.

This isn't Sarah's fault. People naturally share positive moments more than negative ones on social media. But viewers should know that feeling "okay" isn't universal, especially in the first few weeks of treatment when side effects peak.

Should you expect to feel better on GLP-1 drugs?

Don't start semaglutide or tirzepatide expecting an immediate mood boost. These medications are designed for weight management and blood sugar control, not emotional wellness.

If you do feel better psychologically, it's more likely because you're seeing results on the scale or eating less. The STEP 4 trial showed that people who stopped semaglutide regained two-thirds of their lost weight within a year, suggesting the psychological benefits probably depend on continued use.

Some people feel worse initially due to nausea, fatigue, or other startup effects. The 0.25mg starting dose exists specifically because jumping to higher doses causes more side effects.

Sarah's experience might be genuine, but it's just one person's story. Your mileage will definitely vary.